Right on. I had thought from previous PR's that VGPR is Biochars Now sales arm which now has 'exclusive' rights to sell its products. That was the whole point of the latest acquisition. That is why I was thrown back and a bit shocked with the latest press release stating they are trying to raise 1 million dollars to increase production. How can they do that if they are sales and distribution? That statement alone makes me step back a bit and wonder what that private placement is going to be used for. I doubt they are just going to give it to their manufacturer (BioChar Now) out of the goodness of their hearts. IMO that press release should have never gone out until details as to how the funds are actually going to be used, and what affect that private placement will have on us common shareholders.
If someone can help clear up the confusion it would be much appreciated. I think all of us should be on that conference call and make sure we ask the tough questions like this.
News 
Market Data 
Discover 
